1. Home
  2. LGVN vs IMCC Comparison

LGVN vs IMCC Comparison

Compare LGVN & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • IMCC
  • Stock Information
  • Founded
  • LGVN 2014
  • IMCC 1980
  • Country
  • LGVN United States
  • IMCC Israel
  • Employees
  • LGVN N/A
  • IMCC 95
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • IMCC Medicinal Chemicals and Botanical Products
  • Sector
  • LGVN Health Care
  • IMCC Health Care
  • Exchange
  • LGVN Nasdaq
  • IMCC Nasdaq
  • Market Cap
  • LGVN 31.2M
  • IMCC 5.0M
  • IPO Year
  • LGVN 2021
  • IMCC N/A
  • Fundamental
  • Price
  • LGVN $3.17
  • IMCC $2.22
  • Analyst Decision
  • LGVN Strong Buy
  • IMCC
  • Analyst Count
  • LGVN 1
  • IMCC 0
  • Target Price
  • LGVN $12.00
  • IMCC N/A
  • AVG Volume (30 Days)
  • LGVN 11.3M
  • IMCC 31.0K
  • Earning Date
  • LGVN 08-09-2024
  • IMCC 08-12-2024
  • Dividend Yield
  • LGVN N/A
  • IMCC N/A
  • EPS Growth
  • LGVN N/A
  • IMCC N/A
  • EPS
  • LGVN N/A
  • IMCC N/A
  • Revenue
  • LGVN $978,000.00
  • IMCC $53,717,060.00
  • Revenue This Year
  • LGVN $137.24
  • IMCC $11.51
  • Revenue Next Year
  • LGVN $50.77
  • IMCC $19.17
  • P/E Ratio
  • LGVN N/A
  • IMCC N/A
  • Revenue Growth
  • LGVN N/A
  • IMCC 12.87
  • 52 Week Low
  • LGVN $0.77
  • IMCC $1.13
  • 52 Week High
  • LGVN $35.60
  • IMCC $8.10
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 54.46
  • IMCC 41.46
  • Support Level
  • LGVN $2.90
  • IMCC $2.16
  • Resistance Level
  • LGVN $4.88
  • IMCC $2.73
  • Average True Range (ATR)
  • LGVN 0.74
  • IMCC 0.35
  • MACD
  • LGVN -0.06
  • IMCC 0.03
  • Stochastic Oscillator
  • LGVN 32.69
  • IMCC 35.62

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Share on Social Networks: